BNT324/DB-1311 trial data show significant antitumor activity in various cancers, with high response rates in small cell lung ...
Researchers have found that a glue ingredient, PVA, can make cancer treatments safer and more effective. When combined with a ...
Opioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the ...
The FDA advised that the on-going VIRAGE Phase 2b study should not be expanded into a Phase 3 study; rather, the optimal path forward for the VCN-01 PDAC program is to conduct a stand-alone Phase 3 ...
For the 54th year, the Festival of Trees celebrates stories like the Thackerays. This year, Ruby was selected as the patient ...
Axel Bleiler, 3, of Jupiter has undergone chemotherapy and radiation treatment for rhabdomyosarcoma since the spring, when an ...
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue. Researchers found ...
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl ...
Novocure Limited NVCR announced meeting the primary endpoint of overall survival (OS) in a late-stage study, which evaluated ...
Relay Therapeutics (RLAY) and Elevar Therapeutics announced an exclusive global licensing agreement for lirafugratinib. Lirafugratinib is a ...
A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.